Premier Health Associates on Wednesday said it partnered with ObjectiveHealth, an integrated research and digital health technology company. Together, the two companies have created an on-site clinical research center that offers patients access to advanced diagnostics and new, innovative treatment options.
The companies’ joint clinical research center, Premier Health Research, will conduct clinical research trials, initially in the areas of digestive diseases and detection of lung and colorectal cancer risks, in addition to precision diagnostics and early-detection cancer screening.
Sparta-based Premier Health Research plans to expand into additional therapeutic areas based on the needs of its patient population.
“Providing access to new therapies and advanced diagnostics has been instrumental in improving the health outcomes of our patients,” Dr. David Bollard, CEO of Premier Health Associates, said. “Our partnership with ObjectiveHealth allows us the opportunity to provide the best possible care options to our patients who have been diagnosed with or are at-risk for serious health conditions.”
The partnership will offer Premier Health Associates’ patients the ability to participate in industry-leading clinical research opportunities, free diagnostics and testing options, while receiving additional care from their provider.
“Premier Health Associates and ObjectiveHealth share the mission to offer broader access to new treatment options,” Colleen Hoke, co-founder and CEO of ObjectiveHealth, said. “The ability to offer more research participation to Premier Health Associates’ patient population is a huge step forward, not only for research, but for community health overall.”